Cargando…
Novel genomic targets of valosin-containing protein in protecting pathological cardiac hypertrophy
Pressure overload-induced cardiac hypertrophy, such as that caused by hypertension, is a key risk factor for heart failure. However, the underlying molecular mechanisms remain largely unknown. We previously reported that the valosin-containing protein (VCP), an ATPase-associated protein newly identi...
Autores principales: | Zhou, Ning, Chen, Xin, Xi, Jing, Ma, Ben, Leimena, Christiana, Stoll, Shaunrick, Qin, Gangjian, Wang, Charles, Qiu, Hongyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582185/ https://www.ncbi.nlm.nih.gov/pubmed/33093614 http://dx.doi.org/10.1038/s41598-020-75128-z |
Ejemplares similares
-
Genomic characterization reveals novel mechanisms underlying the valosin-containing protein-mediated cardiac protection against heart failure
por: Zhou, Ning, et al.
Publicado: (2020) -
The valosin‐containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload
por: Zhou, Ning, et al.
Publicado: (2017) -
Functional Inhibition of Valosin-Containing Protein Induces Cardiac Dilation and Dysfunction in a New Dominant-Negative Transgenic Mouse Model
por: Sun, Xiaonan, et al.
Publicado: (2021) -
VCP represses pathological cardiac hypertrophy
por: Zhou, Ning, et al.
Publicado: (2017) -
The valosin-containing protein is a novel mediator of mitochondrial respiration and cell survival in the heart in vivo
por: Lizano, Paulo, et al.
Publicado: (2017)